MedTrace Logo

Chronic Obstructive Pulmonary Disease (COPD) Co-Pilot AIR Substudy of CLN0014

NCT03267992 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 9

Last updated 2021-07-16

No results posted yet for this study

Summary

The purpose of undertaking CLN0020, which was a Substudy of the European Coil registry (CLN0014), was to investigate the use of COPD Co-Pilot AIR™, a COPD disease management program manufactured and operated by HGE Health Care Solutions, LLC, in participants undergoing the PneumRx Endobronchial Coil Treatment in a post-market setting.

Conditions

  • COPD Symptoms After Coil Procedure

Interventions

BEHAVIORAL

COPD Co-Pilot AIR App

App. For COPD symptoms after Coil procedure

Sponsors & Collaborators

  • PneumRx, Inc.

    collaborator INDUSTRY

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Daniel Franzen, MD · Klinik für Pneumologie, Zurich

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-10
Primary Completion
2018-10-20
Completion
2018-10-20

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03267992 on ClinicalTrials.gov